James has been working in the life science sector for 12 years, building experience in market access, innovation management and discovery and development. He has a PhD in Pharmacy from the University of Nottingham in which he investigated barriers to adoption and reimbursement of biologic therapies. James takes the lead on a broad portfolio of projects focussed on support the uptake of innovative medicines, med tech and digital to improve patient care. James is currently the national AHSN lead for the AAC Asthma Biologics programme.